All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Zosano Pharma Corporation revenue reports

Zosano Pharma Corporation financial reports, Zosano Pharma Corporation annual revenue in 2024. When does Zosano Pharma Corporation report revenue?
Add to widgets
Added to widgets

Zosano Pharma Corporation total revenue, net income and dynamics of changes in US dollar today

The dynamics of Zosano Pharma Corporation net revenue has changed by 34 000 $ over the last period. Net income Zosano Pharma Corporation - -8 142 000 $. Information about net income is used from open sources. The dynamics of net income of Zosano Pharma Corporation has changed by -44 000 $ in recent years. Graph of the financial report of Zosano Pharma Corporation. The financial report chart on our website displays information by dates from 30/06/2017 to 31/03/2021. The value of all Zosano Pharma Corporation assets on the graph is shown in green.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 258 000 $ - -8 142 000 $ -
31/12/2020 224 000 $ - -8 098 000 $ -
30/09/2020 0 $ - -8 687 000 $ -
30/06/2020 0 $ - -7 895 000 $ -
30/09/2019 0 $ - -9 863 000 $ -
30/06/2019 0 $ - -9 360 000 $ -
31/03/2019 0 $ - -9 426 000 $ -
31/12/2018 0 $ - -10 147 000 $ -
30/09/2018 0 $ - -8 169 000 $ -
30/06/2018 0 $ - -8 836 000 $ -
31/03/2018 0 $ - -8 206 000 $ -
31/12/2017 0 $ - -7 489 000 $ -
30/09/2017 0 $ - -7 873 000 $ -
30/06/2017 0 $ - -6 746 000 $ -
Show:
to

Zosano Pharma Corporation financial report charts

The latest dates of Zosano Pharma Corporation financial statements available online: 30/06/2017, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of Zosano Pharma Corporation for today is 31/03/2021. Gross profit Zosano Pharma Corporation is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Zosano Pharma Corporation is -5 234 000 $

Zosano Pharma Corporation quarterly report dates

Cost of revenue Zosano Pharma Corporation is the total cost of producing and distributing of products and services of a company. Cost of revenue Zosano Pharma Corporation is 5 492 000 $ Total revenue Zosano Pharma Corporation refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Zosano Pharma Corporation is 258 000 $ Operating income Zosano Pharma Corporation is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Zosano Pharma Corporation is -8 048 000 $

Net income Zosano Pharma Corporation is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Zosano Pharma Corporation is -8 142 000 $ Current assets Zosano Pharma Corporation is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Zosano Pharma Corporation is 28 473 000 $ Total assets Zosano Pharma Corporation refers to the total amount of assets owned by a person or entity. Total assets Zosano Pharma Corporation is 65 710 000 $

31/03/2021 31/12/2020 30/09/2020 30/06/2020 30/09/2019 30/06/2019 31/03/2019 31/12/2018 30/09/2018 30/06/2018 31/03/2018 31/12/2017 30/09/2017 30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-5 234 000 $ -5 299 000 $ -5 824 000 $ -4 932 000 $ -6 486 000 $ -6 640 000 $ -6 616 000 $ -7 270 000 $ - - - - - -
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
5 492 000 $ 5 523 000 $ 5 824 000 $ 4 932 000 $ 6 486 000 $ 6 640 000 $ 6 616 000 $ 7 270 000 $ - - - - - -
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
258 000 $ 224 000 $ - - - - - - - - - - - -
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - - - - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-8 048 000 $ -7 936 000 $ -8 528 000 $ -7 698 000 $ -9 557 000 $ -9 407 000 $ -9 487 000 $ -9 740 000 $ -8 252 000 $ -8 805 000 $ -8 066 000 $ -7 352 000 $ -7 719 000 $ -6 551 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-8 142 000 $ -8 098 000 $ -8 687 000 $ -7 895 000 $ -9 863 000 $ -9 360 000 $ -9 426 000 $ -10 147 000 $ -8 169 000 $ -8 836 000 $ -8 206 000 $ -7 489 000 $ -7 873 000 $ -6 746 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
- - - - - - 6 616 000 $ 7 270 000 $ 5 899 000 $ 6 533 000 $ 5 806 000 $ 5 516 000 $ 5 683 000 $ 4 363 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
8 306 000 $ 8 160 000 $ 8 528 000 $ 7 698 000 $ 9 557 000 $ 9 407 000 $ 9 487 000 $ 9 740 000 $ 8 252 000 $ 8 805 000 $ 8 066 000 $ 7 352 000 $ 7 719 000 $ 6 551 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
28 473 000 $ 35 716 000 $ 44 169 000 $ 11 246 000 $ 7 271 000 $ 18 731 000 $ 11 959 000 $ 23 360 000 $ 30 545 000 $ 38 507 000 $ 5 507 000 $ 13 393 000 $ 21 184 000 $ 29 391 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
65 710 000 $ 72 011 000 $ 80 452 000 $ 47 712 000 $ 36 668 000 $ 45 787 000 $ 35 523 000 $ 35 780 000 $ 38 855 000 $ 45 226 000 $ 10 372 000 $ 18 000 000 $ 25 879 000 $ 34 644 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
26 882 000 $ 35 263 000 $ 43 554 000 $ 10 547 000 $ 6 492 000 $ 14 252 000 $ 6 142 000 $ 9 140 000 $ 11 997 000 $ 16 232 000 $ 3 572 000 $ 11 651 000 $ 13 292 000 $ 21 159 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 14 126 000 $ 15 295 000 $ 15 160 000 $ 11 287 000 $ - 3 600 000 $ 5 160 000 $ 6 687 000 $ 6 229 000 $ 6 118 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - - 29 476 000 $ 37 638 000 $ 3 537 000 $ 11 651 000 $ 19 849 000 $ 28 225 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 26 289 000 $ 26 780 000 $ 25 872 000 $ 17 070 000 $ - - - - 8 177 000 $ 9 634 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 71.69 % 58.49 % 72.83 % 47.71 % - - - - 31.60 % 27.81 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
43 151 000 $ 47 515 000 $ 55 244 000 $ 18 464 000 $ 10 379 000 $ 19 007 000 $ 9 651 000 $ 18 710 000 $ 28 500 000 $ 36 080 000 $ -1 019 000 $ 7 048 000 $ 14 233 000 $ 21 957 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - -8 736 000 $ -11 145 000 $ -7 469 000 $ -6 752 000 $ -7 977 000 $ -8 257 000 $ -6 136 000 $ -6 164 000 $ -6 830 000 $ -7 149 000 $

Last revenue report of Zosano Pharma Corporation was 31/03/2021. According to last financial report total revenue in Zosano Pharma Corporation was 258 000 US dollar and changed by 0% since last year. Net income in Zosano Pharma Corporation was -8 142 000 $ in last quartal, net income changes to 0%.

Current cash Zosano Pharma Corporation - the sum of all of the cash a company has on the date of report. Current cash Zosano Pharma Corporation is 26 882 000 $

Zosano Pharma Corporation stocks data

Zosano Pharma Corporation financials